Table 3.
Objective | ||||
---|---|---|---|---|
Clinical Endpoint | Advocacy | Regulatory/Licensure | Policy and Post-Licensure Evaluation | Financing |
ARF |
|
|
|
|
RHD |
|
|
|
|
APSGN |
|
|
|
|
Abbreviations: APSGN, acute post-streptococcal glomerulonephritis; ARF, acute rheumatic fever; HIC, high-income country; LMIC, low- and middle-income country; RHD, rheumatic heart disease.